The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3279-3288

  Grover, Harshita Satija ^a   Blanchard, Nicolas ^a,b   Gonzalez, Federico ^a   Chan, Shiao ^a   Robey, Ellen A ^a   Shastri, Nilabh ^a  

^a University of California Berkeley   (United States)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AS15 PEPTIDE; BETA GALACTOSIDASE; COMPLEMENTARY DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTOZOAL PROTEIN; T LYMPHOCYTE ANTIGEN; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA ISOLATION; DNA LIBRARY; HYBRIDOMA; IMMUNIZATION; MOUSE; NONHUMAN; PARASITE CONTROL; PARASITE IMMUNITY; PARASITE LOAD; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED C57BL; PARASITE LOAD; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84867591997     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00425-12     Document Type: Article

References (65)

1. Andersen P, Andersen AB, Sorensen AL, Nagai S. 1995. Recall of longlived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
2. Araujo FG. 1991. Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice. Infect. Immun. 59:1614-1619.
3. Blackwell JM, Roberts CW, Alexander J. 1993. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immunol. 15:317-324.
4. Blanchard N, et al. 2008. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat. Immunol. 9:937-944.
5. Boothroyd JC. 2009. Toxoplasma gondii: 25 years and 25 major advances for the field. Int. J. Parasitol. 39:935-946.
6. Brown CR, et al. 1995. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419-428.
7. Brown CR, McLeod R. 1990. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 145: 3438-3441.
8. Campbell DJ, Shastri N. 1998. Bacterial surface proteins recognized by CD4+ T cells during murine infection with Listeria monocytogenes. J. Immunol. 161:2339-2347.
9. Carruthers VB. 2002. Host cell invasion by the opportunistic pathogen Toxoplasma gondii. Acta Trop. 81:111-122.
10. Chtanova T, et al. 2009. Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node. Immunity 31:342-355.
11. Cong H, et al. 2011. Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLAA*0201. Vaccine 29:754-762.
12. Cookson BT, Bevan MJ. 1997. Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J. Immunol. 158:4310-4319.
13. Deckert-Schluter M, et al. 1994. Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response. Infect. Immun. 62:221-228.
14. Denkers EY. 1999. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect. 1:699-708.
15. Denkers EY, Gazzinelli RT. 1998. Regulation and function of T-cellmediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:569-588.
16. Frickel EM, et al. 2008. Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J. Infect. Dis. 198: 1625-1633.
17. Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A. 1991. Synergistic role of CD4+and CD8+T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286-292.
18. Grillot D, et al. 1990. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur. J. Immunol. 20:1215-1222.
19. Hakim FT, et al. 1991. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147:2310-2316.
20. Harris DP, et al. 1995. Cross-recognition by T cells of an epitope shared by two unrelated mycobacterial antigens. Eur. J. Immunol. 25:3173-3179.
21. Hess J, Ladel C, Miko D, Kaufmann SH. 1996. Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J. Immunol. 156:3321-3326.
22. Hirunpetcharat C, et al. 1997. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J. Immunol. 159:3400-3411.
23. Israelski DM, Remington JS. 1993. Toxoplasmosis in patients with cancer. Clin. Infect. Dis. 17(Suppl. 2):S423-S435.
24. Jankovic D, et al. 2007. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204:273-283.
25. Jardim A, Alexander J, Teh HS, Ou D, Olafson RW. 1990. Immunoprotective Leishmania major synthetic T cell epitopes. J. Exp. Med. 172: 645-648.
26. Kahn SJ, Wleklinski M. 1997. The surface glycoproteins of Trypanosoma cruzi encode a superfamily of variant T cell epitopes. J. Immunol. 159: 4444-4451.
27. Karttunen J, Sanderson S, Shastri N. 1992. Detection of rare antigenpresenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. U.S.A. 89:6020- 6024.
28. Karttunen J, Shastri N. 1991. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc. Natl. Acad. Sci. U.S.A. 88:3972-3976.
29. Kim K, Weiss LM. 2004. Toxoplasma gondii: the model apicomplexan. Int. J. Parasitol. 34:423- 432.
30. Kirisits MJ, Mui E, McLeod R. 2000. Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii. Int. J. Parasitol. 30:149-155.
31. Kwok LY, et al. 2003. The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. J. Immunol. 170:1949-1957.
32. Lang C, Gross U, Luder CG. 2007. Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol. Res. 100:191-203.
33. Liesenfeld O, Kosek J, Remington JS, Suzuki Y. 1996. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184:597- 607.
34. Luder CG, et al. 2003. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA. J. Neuroimmunol. 134:12-24.
35. Luder CG, Lang T, Beuerle B, Gross U. 1998. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin. Exp. Immunol. 112:308-316.
36. Luft BJ, Remington JS. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-222.
37. Lutjen S, Soltek S, Virna S, Deckert M, Schluter D. 2006. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-Tcell responses by CD4 T cells. Infect. Immun. 74:5790-5801.
38. Malarkannan S, Mendoza LM, Shastri N. 2001. Generation of antigenspecific, lacZ-inducible T-cell hybrids. Methods Mol. Biol. 156:265-272.
39. McKee AS, Dzierszinski F, Boes M, Roos DS, Pearce EJ. 2004. Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii. J. Immunol. 173:2632-2640.
40. Mendes EA, Caetano BC, Penido ML, Bruna-Romero O, Gazzinelli RT. 2011. MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8(+) T lymphocytes. Vaccine 29:4476-4484.
41. Mougneau E, et al. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563-566.
42. Musson JA, et al. 2002. Processing of viable Salmonella typhimurium for presentation of a CD4 T cell epitope from the Salmonella invasion protein C (SipC). Eur. J. Immunol. 32:2664-2671.
43. Oldenhove G, et al. 2009. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31:772-786.
44. Parker SJ, Roberts CW, Alexander J. 1991. CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin. Exp. Immunol. 84:207-212.
45. Pepper M, Dzierszinski F, Crawford A, Hunter CA, Roos D. 2004. Development of a system to study CD4+-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infect. Immun. 72:7240-7246.
46. Reece WH, et al. 2004. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med. 10:406- 410.
47. Reichmann G, Dlugonska H, Fischer HG. 1997. T cell receptor specificities of Toxoplasma gondii-reactive mouse CD4+T lymphocytes and Th1 clones. Med. Microbiol. Immunol. 186:25-30.
48. Reichmann G, Dlugonska H, Hiszczynska-Sawicka E, Fischer H. 2001.Tachyzoite-specific isoform of Toxoplasma gondii lactate dehydrogenase is the target antigen of a murine CD4(+) T-cell clone. Microbes Infect. 3:779-787.
49. Reichmann G, et al. 1997. Detection of a novel 40,000 MW excretory Toxoplasma gondii antigen by murine Th1 clone which induces toxoplasmacidal activity when exposed to infected macrophages. Immunology 92: 284-289.
50. Sahara H, Shastri N. 2003. Second class minors: molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules. J. Exp. Med. 197: 375-385.
51. Sanderson S, Campbell DJ, Shastri N. 1995. Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning. J. Exp. Med. 182:1751-1757.
52. Sanderson S, Shastri N. 1994. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6:369-376.
53. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-1684.
54. Stumhofer JS, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937-945.
55. Suzuki Y, Conley FK, Remington JS. 1989. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143:2045-2050.
56. Suzuki Y, et al. 1994. MHC class I gene(s) in the D/L region but not the TNF-alpha gene determines development of toxoplasmic encephalitis in mice. J. Immunol. 153:4649-4654.
57. Suzuki Y, Joh K, Orellana MA, Conley FK, Remington JS. 1991. A gene (s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732-739.
58. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. 1988. Interferongamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
59. Suzuki Y, Remington JS. 1988. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J. Immunol. 140:3943-3946.
60. Takita-Sonoda Y, et al. 1996. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Exp. Parasitol. 84:223-230.
61. Williams DM, Grumet FC, Remington JS. 1978. Genetic control of murine resistance to Toxoplasma gondii. Infect. Immun. 19:416-420.
62. Wilson DC, et al. 2010. Differential regulation of effector- and centralmemory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells. PLoS Pathog. 6:e1000815. doi: 10.1371/journal.ppat.1000815.
63. Yanagisawa S, Koike M, Kariyone A, Nagai S, Takatsu K. 1997. Mapping of V beta 11+ helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis. Int. Immunol. 9:227-237.
64. Yang DM, Rogers MV, Liew FY. 1991. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major. Immunology 72:3-9.
65. Yarovinsky F, Kanzler H, Hieny S, Coffman RL, Sher A. 2006. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response. Immunity 25:655- 664.